When compared to the SAPIEN 3 and SAPIEN 3 Ultra valves, a study utilizing Edwards' most recent TAVR technology, the SAPIEN 3 Ultra RESILIA valve, revealed larger effective orifice areas across ...

Over the last two decades, Edwards Lifesciences has demonstrated that it knows how to maintain leadership through innovation of tissue heart valves. Edwards remains the dominant force in surgical ...

Edwards Lifesciences beat analysts' estimate for fourth-quarter profit on Tuesday, helped by strong demand for its artificial heart valves and other medical devices.